Daklinza (daclatasvir)

pCPA File Number: 20876
Negotiation Status:
Concluded without agreement
Indication(s):
Chronic Hepatitis C
Sponsor/Manufacturer:
Bristol Myers Squibb Canada Inc.
CDA-AMC Project Number:
SR0417-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: